Comparison of read-through effects of aminoglycosides and PTC124 on rescuing nonsense mutations of HERG gene associated with long QT syndrome

Yu,Haiyun; Liu,Xiaoyan; Huang,Jian; Zhang,Yinhui; Hu,Roumu; Pu,Jielin

doi:10.3892/ijmm.2013.1601

Comparison of read-through effects of aminoglycosides and PTC124 on rescuing nonsense mutations of HERG gene associated with long QT syndrome

Authors:
- Haiyun Yu
- Xiaoyan Liu
- Jian Huang
- Yinhui Zhang
- Roumu Hu
- Jielin Pu
View Affiliations

Affiliations: State Key Laboratory of Cardiovascular Disease, Physiology and Pathophysiology Laboratory, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, P.R. China
Published online on: December 23, 2013 https://doi.org/10.3892/ijmm.2013.1601
Pages: 729-735

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Aminoglycosides promote the readthrough of premature stop codons introduced by nonsense mutations to produce full-length proteins in genetic disease models. The read-through effects of different aminoglycosides and PTC124 on HERG gene have yet to be adequately elucidated. The wild‑type (WT) or mutant genes were transiently transfected in HEK293 cells. The read-through effect was examined by adding drugs into culture medium for 24 h. Western blot analysis and patch clamping were performed to evaluate the expression and function of the genes. The mRNA levels were determined using qPCR. The results showed that G418 and PTC124 significantly increased the protein expression of R1014X mutant in a dose-dependent manner and produced a full-length protein. The maximal protein levels after G418, gentamicin or PTC124 treatment were 39.1±2.4, 18.6±0.3 or 10.3±1.0%, respectively, of the WT level. Tobramycin did not exhibit a read-through effect. The mRNA levels, however, did not differ between WT and mutant gene. The tail current densities of R1014X channels at 40 mV were 22.57±2.26 pA/pF for G418, 16.21±1.49 pA/pF for gentamicin and 9.62±0.73 pA/pF for PTC124. The leftward shift of the activation curve was corrected only by G418 and gentamicin. The read-through effects of W927X, R863X and E698X revealed that as the mutation site approached the N-terminal, the rescue efficiency was decreased. The above results suggest that aminoglycosides and PTC124 induced different effects on rescue nonsense mutations of the HERG gene. The mutation site was a significant factor in determining the pharmacological rescue efficiency.

View Figures

View References

1	Splawski I, Shen J, Timothy KW, et al: Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 102:1178–1185. 2000. View Article : Google Scholar : PubMed/NCBI
2	Anderson CL, Delisle BP, Anson BD, et al: Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation. 113:365–373. 2006. View Article : Google Scholar : PubMed/NCBI
3	Lee HL and Dougherty JP: Pharmaceutical therapies to recode nonsense mutations in inherited diseases. Pharmacol Ther. 136:227–266. 2012. View Article : Google Scholar : PubMed/NCBI
4	Zilberberg A, Lahav L and Rosin-Arbesfeld R: Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons. Gut. 59:496–507. 2010. View Article : Google Scholar : PubMed/NCBI
5	Malik V, Rodino-Klapac LR, Viollet L, et al: Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy. Ann Neurol. 67:771–780. 2010.PubMed/NCBI
6	Howard M, Frizzell RA and Bedwell DM: Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nat Med. 2:467–469. 1996. View Article : Google Scholar : PubMed/NCBI
7	Yao Y, Teng S, Li N, Zhang Y, Boyden PA and Pu J: Aminoglycoside antibiotics restore functional expression of truncated HERG channels produced by nonsense mutations. Heart Rhythm. 6:553–560. 2009. View Article : Google Scholar : PubMed/NCBI
8	Wilschanski M, Miller LL, Shoseyov D, et al: Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis. Eur Respir J. 38:59–69. 2011. View Article : Google Scholar : PubMed/NCBI
9	Goldmann T, Overlack N, Wolfrum U and Nagel-Wolfrum K: PTC124-mediated translational readthrough of a nonsense mutation causing Usher syndrome type 1C. Hum Gene Ther. 22:537–547. 2011. View Article : Google Scholar : PubMed/NCBI
10	Tan L, Narayan SB, Chen J, Meyers GD and Bennett MJ: PTC124 improves readthrough and increases enzymatic activity of the CPT1A R160X nonsense mutation. J Inherit Metab Dis. 34:443–447. 2011. View Article : Google Scholar : PubMed/NCBI
11	Welch EM, Barton ER, Zhuo J, et al: PTC124 targets genetic disorders caused by nonsense mutations. Nature. 447:87–91. 2007. View Article : Google Scholar : PubMed/NCBI
12	Crotti L, Celano G, Dagradi F and Schwartz PJ: Congenital long QT syndrome. Orphanet J Rare Dis. 3:182008. View Article : Google Scholar : PubMed/NCBI
13	Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED and Keating MT: A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 80:795–803. 1995. View Article : Google Scholar : PubMed/NCBI
14	Alders M and Mannens M: Romano-Ward Syndrome. Pagon RA, Adam MP, Bird TD, et al: GeneReviews™ (internet). University of Washington; Seattle, WA: 2003, http://www.ncbi.nlm.nih.gov/books/NBK1129/. Last update: May 31, 2012.
15	Schweingruber C, Rufener SC, Zünd D, Yamashita A and Mühlemann O: Nonsense-mediated mRNA decay - mechanisms of substrate mRNA recognition and degradation in mammalian cells. Biochim Biophys Acta. 1829:612–623. 2013. View Article : Google Scholar : PubMed/NCBI
16	Akhavan A, Atanasiu R, Noguchi T, Han W, Holder N and Shrier A: Identification of the cyclic-nucleotide-binding domain as a conserved determinant of ion-channel cell-surface localization. J Cell Sci. 118:2803–2812. 2005. View Article : Google Scholar : PubMed/NCBI
17	Akhavan A, Atanasiu R and Shrier A: Identification of a COOH-terminal segment involved in maturation and stability of human ether-a-go-go-related gene potassium channels. J Biol Chem. 278:40105–40112. 2003. View Article : Google Scholar : PubMed/NCBI
18	Moazed D and Noller HF: Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature. 327:389–394. 1987. View Article : Google Scholar : PubMed/NCBI
19	Kondo J, Urzhumtsev A and Westhof E: Two conformational states in the crystal structure of the Homo sapiens cytoplasmic ribosomal decoding A site. Nucleic Acids Res. 34:676–685. 2006. View Article : Google Scholar : PubMed/NCBI
20	Kondo J, Francois B, Urzhumtsev A and Westhof E: Crystal structure of the Homo sapiens cytoplasmic ribosomal decoding site complexed with apramycin. Angew Chem Int Ed Engl. 45:3310–3314. 2006. View Article : Google Scholar : PubMed/NCBI
21	Hermann T, Tereshko V, Skripkin E and Patel DJ: Apramycin recognition by the human ribosomal decoding site. Blood Cells Mol Dis. 38:193–198. 2007. View Article : Google Scholar : PubMed/NCBI
22	Amrani N, Ganesan R, Kervestin S, Mangus DA, Ghosh S and Jacobson A: A faux 3′-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay. Nature. 432:112–118. 2004.
23	Floquet C, Deforges J, Rousset JP and Bidou L: Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides. Nucleic Acids Res. 39:3350–3362. 2011. View Article : Google Scholar : PubMed/NCBI
24	De Luca A, Nico B, Rolland JF, et al: Gentamicin treatment in exercised mdx mice: identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle. Neurobiol Dis. 32:243–253. 2008.PubMed/NCBI
25	Manuvakhova M, Keeling K and Bedwell DM: Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system. RNA. 6:1044–1055. 2000. View Article : Google Scholar : PubMed/NCBI
26	Du M, Liu X, Welch EM, Hirawat S, Peltz SW and Bedwell DM: PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model. Proc Natl Acad Sci USA. 105:2064–2069. 2008. View Article : Google Scholar : PubMed/NCBI
27	Kerem E, Hirawat S, Armoni S, et al: Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet. 372:719–727. 2008. View Article : Google Scholar : PubMed/NCBI
28	Ho G, Reichardt J and Christodoulou J: In vitro read-through of phenylalanine hydroxylase (PAH) nonsense mutations using aminoglycosides: a potential therapy for phenylketonuria. J Inherit Metab Dis. Mar 27–2013.(Epub ahead of print).
29	Brumm H, Mühlhaus J, Bolze F, et al: Rescue of melanocortin 4 receptor (MC4R) nonsense mutations by aminoglycoside-mediated read-through. Obesity (Silver Spring). 20:1074–1081. 2012. View Article : Google Scholar : PubMed/NCBI
30	Dranchak PK, Di Pietro E, Snowden A, et al: Nonsense suppressor therapies rescue peroxisome lipid metabolism and assembly in cells from patients with specific PEX gene mutations. J Cell Biochem. 112:1250–1258. 2011. View Article : Google Scholar : PubMed/NCBI
31	Bartolomeo R, Polishchuk EV, Volpi N, Polishchuk RS and Auricchio A: Pharmacological read-through of nonsense ARSB mutations as a potential therapeutic approach for mucopolysaccharidosis VI. J Inherit Metab Dis. 36:363–371. 2013. View Article : Google Scholar : PubMed/NCBI
32	Engelberg-Kulka H: UGA suppression by normal tRNA Trp in Escherichia coli: codon context effects. Nucleic Acids Res. 9:983–991. 1981. View Article : Google Scholar : PubMed/NCBI
33	Nilsson M and Ryden-Aulin M: Glutamine is incorporated at the nonsense codons UAG and UAA in a suppressor-free Escherichia coli strain. Biochim Biophys Acta. 1627:1–6. 2003. View Article : Google Scholar : PubMed/NCBI
34	Brendel C, Belakhov V, Werner H, et al: Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model. J Mol Med (Berl). 89:389–398. 2011. View Article : Google Scholar : PubMed/NCBI